App-Quantinova.ai

Pulmonary Function in Patients with Congenitial Heart Disease

R. P. Cusack - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Automated Approaches to Reducing Variability in Oscillometry and Effects on Respiratory System Impedance

J. Tjong - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Salbutamol

Assessment of Intrabreath Mechanics from Conventional Oscillometry Measurements

Z. Hantos - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Home Deaths in Idiopathic Pulmonary Fibrosis: An Autopsy Study

E. Wall - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Idiopathic pulmonary fibrosis

N/A

Investigating the Expression of CCL18 in Alternatively Activated Macrophages and in the Progression of Different Fibrotic Lung Diseases

A. Ayoub - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Extrinsic allergic alveolitis

ILS-969

The IRE/XBP1 Pathway Is Activated in Alternatively Activated Macrophages in Interstitial Fibrotic Lung Disease

M. Vierhout - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

Phorbol myristate acetate

1 Is a Marker of Alternatively Activated Macrophages and a Therapeutic Target in Interstitial Fibrotic Lung Diseases

M. El Taweel - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

Bleomycin

Inhibition of Nasal and Systemic IgA Responses by Cigarette Smoke Exposure in Mice

J. McGrath - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Systemic Inflammation Is Key to Understanding the Link Between Concomitant Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

M. Abou Rjeili - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Chronic obstructive pulmonary disease

ICAM-1

Nintedanib: A Potent Inhibitor of Invadosome Formation by Lung Fibroblasts Derived from Patients with Idiopathic Pulmonary Fibrosis

M. Lebel - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Nintedanib

Induced Apoptosis

R. Soares Godoy - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Fibrotic microRNA of Fibrocytes in Bronchoalveolar Lavage Fluid

S. Sato - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Idiopathic pulmonary fibrosis

DE-074

Induced Pulmonary Fibrosis Rat Model

T. Yanagihara - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary fibrosis

Pirfenidone

On for the Treatment of IPF Exacerbations

J. Parker - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Bleomycin

Asthma, COPD, Respiratory Infections and Viruses: Admission Rates, ER Visits and Age

R. P. Cusack - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Altered M1 and M2 Macrophage Distribution and Impaired Phagocytic Activity in HIV Airways

K. Akata - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Infected Donors

J. Yang - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Effect of Transitioning from Phosphodiesterase Type 5 Inhibitors to Riociguat

K. Sun - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Riociguat

Induced Relaxation of Rat Pulmonary Arteries with Intact and Denuded Endothelium

M. R. Corboz - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Prostaglandin

Mild Chronic Obstructive Pulmonary Disease (COPD) and the Presence of Dyspnea: Inferences from the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Study

M. Cherian - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Chronic obstructive pulmonary disease

N/A

Filters

28841 Abstracts